Cohance Lifesciences Limited
COHANCE
Rankning i aktier
#6488
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aktiekurs
$4.80
Marknadsvärde
$1.84B
Förändring (1 dag)
-5.65%
Förändring (1 år)
-59.50%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Aktiekurshistorik för Cohance Lifesciences Limited (COHANCE)
Högsta slutkurs: $12.03 den 2025-06-01
Lägsta slutkurs: $1.65 den 2020-03-01
Lägsta slutkurs: $1.65 den 2020-03-01
Aktiekurshistorik för Cohance Lifesciences Limited från 2020 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2025 | -17.24% |
| 2024 | 75.72% |
| 2023 | 43.40% |
| 2022 | -12.41% |
| 2021 | 15.53% |
| 2020 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
